[HTML][HTML] Ankylosing spondylitis: etiology, pathogenesis, and treatments

W Zhu, X He, K Cheng, L Zhang, D Chen, X Wang… - Bone research, 2019 - nature.com
Ankylosing spondylitis (AS), a common type of spondyloarthropathy, is a chronic
inflammatory autoimmune disease that mainly affects spine joints, causing severe, chronic …

[HTML][HTML] Immune cells involved in the pathogenesis of ankylosing spondylitis

A Rezaiemanesh, M Abdolmaleki… - Biomedicine & …, 2018 - Elsevier
Ankylosing spondylitis (AS) is an inflammatory autoimmune disease. AS is a prototype form
of spondyloarthropathies (SpA). The precise etiology of AS has not been fully understood …

[HTML][HTML] Pharmacological-and non-pharmacological therapeutic approaches in inflammatory bowel disease in adults

GC Leitner, H Vogelsang - World journal of gastrointestinal …, 2016 - ncbi.nlm.nih.gov
Inflammatory bowel diseases (IBDs) are a group of chronic inflammatory conditions mainly
of the colon and small intestine. Crohn's disease (CD) and ulcerative colitis (UC) are the …

[HTML][HTML] Monocyte populations as markers of response to adalimumab plus MTX in rheumatoid arthritis

L Chara, A Sánchez-Atrio, A Pérez, E Cuende… - Arthritis research & …, 2012 - Springer
Introduction The treatment of rheumatoid arthritis (RA) patients with anti-tumor necrosis
factor alpha (TNFα) biological drugs has dramatically improved the prognosis of these …

Detection of synovial macrophages in an experimental rabbit model of antigen-induced arthritis: ultrasmall superparamagnetic iron oxide–enhanced MR imaging

AM Lutz, C Seemayer, C Corot, RE Gay, K Goepfert… - Radiology, 2004 - pubs.rsna.org
PURPOSE: To evaluate intravenously administered ultrasmall superparamagnetic iron
oxide (USPIO) as a marker of macrophage activity in an experimental rabbit model of …

Granulocyteaphaeresis in steroid‐dependent inflammatory bowel disease: a prospective, open, pilot study

E Domènech, J Hinojosa… - Alimentary …, 2004 - Wiley Online Library
Background: Uncontrolled studies suggest that granulocyteaphaeresis might be useful in the
management of active ulcerative colitis. Aim: To assess the efficacy of …

Apoptotic cells ameliorate chronic intestinal inflammation by enhancing regulatory B-cell function

MMU Ansary, S Ishihara, A Oka… - Inflammatory Bowel …, 2014 - academic.oup.com
Apoptosis is a programmed physiological death of unwanted cells, and handling of apoptotic
cells (ACs) is thought to have profound effects on immune-mediated disorders. However …

A pilot open-labeled prospective randomized study between weekly and intensive treatment of granulocyte and monocyte adsorption apheresis for active ulcerative …

A Sakuraba, T Sato, M Naganuma, Y Morohoshi… - Journal of …, 2008 - Springer
Background. Recently, granulocyte and monocyte adsorption apheresis (GMA) has been
shown to be effective for active ulcerative colitis (UC). Its original weekly treatment schedule …

Granulocyte and monocyte adsorptive apheresis for pyoderma gangrenosum

Y Higashi, A Ibusuki, N Baba… - Therapeutic …, 2022 - Wiley Online Library
Pyoderma gangrenosum (PG), a chronic aseptic inflammatory skin disease characterized by
skin ulcers with elevated and undermined borders, is resistant to conventional therapies. PG …

Adsorptive granulocyte/monocyte apheresis for the treatment of refractory rheumatoid arthritis: an open pilot multicentre trial

R Sanmarti, S Marsal, J Valverde, E Casado… - …, 2005 - academic.oup.com
Objective. To assess the efficacy and safety of adsorptive granulocyte and monocyte
apheresis (GCAP) in patients with refractory rheumatoid arthritis (RA). Methods. Patients …